Objective
Research on sequencing the human genome and those of pathogenesis organisms provide information which promise developments in the drug discovery process. The purpose of the meeting is to assemble the achievements of structure-based drug design and to review future prospective. By discussing real life examples, the underlying principles, strengths and weaknesses of the approach will be argued, from protein structures to emerging techniques (bio computation, combinatorial chemistry, high throughput screening), from advances in structural methods (X-ray and cry-electron diffraction, synchrotron radiation, NMR & mass spectrometry, modelling) to structure prediction (threading sequences , evolution, fold assignment) ; a strong accent will be put on the synergistic use of each of them in order to prospect an efficient drug design .
Fields of science
- medical and health sciencesbasic medicinemedicinal chemistry
- natural sciencesearth and related environmental sciencesgeologymineralogycrystallography
- natural sciencesbiological sciencesbiochemistrybiomoleculesproteins
- natural scienceschemical sciencesanalytical chemistrymass spectrometry
- natural sciencesbiological sciencesgeneticsgenomes
Topic(s)
Data not availableCall for proposal
Data not availableFunding Scheme
ACM - Preparatory, accompanying and support measuresCoordinator
40127 BOLOGNA
Italy